Kolmar Korea
한국콜마 · 161890
Materials Chemicals · KOSPI
Market cap US$1.4B (₩2T)
Overview
Kolmar Korea develops and manufactures cosmetics, including skincare, functional, and colour products, as well as prescription pharmaceuticals, health and wellness products, and cosmetic packaging, supplying brand owners who place orders under their own labels.
Listed on KOSPI, Korea's main stock exchange, it serves cosmetics brands, pharmaceutical companies, and retailers across domestic and international markets. The vast majority of its cosmetics revenue comes from an ODM (original development and design manufacturing) model, meaning it owns the formulation technology itself rather than simply following a client's recipe.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$1.6B
- FY2024US$1.8B
- FY2025US$2B
Operating profit
- FY2023US$98.7M
- FY2024US$140.5M
- FY2025US$173.6M
Net income
- FY2023US$18.2M
- FY2024US$90.8M
- FY2025US$121.9M
Key ratios (FY2025)
Why it matters
Kolmar Korea was spun off from the original 한국콜마㈜ and now operates as a holding-style group with subsidiaries spanning cosmetics, packaging, and pharmaceuticals across Korea, China, and North America.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?